Skip to main content
Clinical Trials/NCT04340778
NCT04340778
Unknown
Phase 3

Comparative Safety and Efficacy of Vaginal Dinoprostone Versus Lidocaine-prilocaine Cream in Copper IUD Insertion in Nulliparous Women: a Randomized Controlled Trial

Cairo University0 sites210 target enrollmentApril 30, 2020

Overview

Phase
Phase 3
Intervention
vaginal dinoprostone
Conditions
Contraception
Sponsor
Cairo University
Enrollment
210
Primary Endpoint
pain during IUD insertion: visual analog scale
Last Updated
6 years ago

Overview

Brief Summary

the aim of the present study is to Compare Safety and Efficacy of Vaginal dinoprostone Versus Lidocaine-prilocaine Cream in copper IUD Insertion in nulliparous women: a randomized controlled trial

Registry
clinicaltrials.gov
Start Date
April 30, 2020
End Date
September 5, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Samy aly ashour

assistant professor obstetrics and gynecology

Cairo University

Eligibility Criteria

Inclusion Criteria

  • nulliparous women requesting copper IUD insertion

Exclusion Criteria

  • multiparous women, active vaginal or cervical infections and contraindications to IUD Insertion.

Arms & Interventions

vaginal dinoprostone

vaginal dinoprostone 3 mg will be given 3 hours before copper IUD insertion plus inert placebo cream will be applied on the cervix at the time of IUD insertion.

Intervention: vaginal dinoprostone

lidocaine prilocaine cream

Lidocaine-prilocaine Cream will be applied on the cervix at the time of copper IUD insertion plus vaginal placebo tablet 3 hours before IUD insertion

Intervention: Lidocaine-prilocaine Cream

placebo

inert placebo Cream will be applied on the cervix at the time of copper IUD insertion plus vaginal placebo tablet 3 hours before IUD insertion

Intervention: placebo

Outcomes

Primary Outcomes

pain during IUD insertion: visual analog scale

Time Frame: 5 minutes

pain during copper IUD insertion evaluated by 10 cm visual analog scale where 0 denotes no pain and 10 cm denotes the worst pain imaginable

Secondary Outcomes

  • duration of insertion(5 minutes)

Similar Trials